• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida

by January 8, 2025
written by January 8, 2025

ZURICH (Reuters) -Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics , a specialist in complex immune cell therapies to treat several types of blood cancer.

Roche said it has accepted for payment nearly 65 million shares in Poseida – equivalent to 66% of the California company’s stock – which had been tendered by shareholders at a price of $9 per share, with an additional contingent payment of up to $4 per share.

The consideration takes the deal value up to around $1.5 billion.

The acquisition, announced in November, is the latest move by Roche to boost its development pipe-line to offset falling oncology sales.

“Later today, Roche intends to complete the acquisition of Poseida …without a vote or meeting of Poseida’s stockholders,” Roche said on Wednesday.

In the takeover, all shares of Poseida not owned by Poseida, or Roche will be converted into the right to receive the same consideration per share, the Swiss company said.

Poseida, which will become a wholly owned subsidiary of Roche, will add so-called allogeneic CAR-T cell therapies, which use genetically modified immune cells to attack cancer cells or to treat auto immune diseases.

Poseida is also working on CAR-T programmes for solid tumours and autoimmune diseases.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Indonesia e-commerce firm Bukalapak to stop selling physical goods as competition mounts
next post
Japan stocks lower at close of trade; Nikkei 225 down 0.27%

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Divided Fed proposes rule to ease capital requirements for big Wall Street banks

      June 26, 2025
    • Women’s Tennis Association extends media rights deal with Tennis Channel through 2032

      June 26, 2025
    • Bumble shares jump 26% as dating company plans to axe 30% of workforce

      June 26, 2025
    • Small-business AI use is lagging, but one firm is channeling Sherlock Holmes and knocking out ‘grunt work’

      June 25, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (534)
    • Stock (6,426)

    Latest News

    • Divided Fed proposes rule to ease capital requirements for big Wall Street banks
    • Women’s Tennis Association extends media rights deal with Tennis Channel through 2032

    Popular News

    • Alcohol stocks fall on a new link between alcohol consumption and cancer risk
    • Arthur J. Gallagher to buy AssuredPartners for $13.45 billion

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy